Search Result "positive anaplastic"
Anaplastic Lymphoma Kinase as a Therapeutic Target in Anaplastic Large Cell Lymphoma, Non-Small Cell Lung Cancer and Neuroblastoma
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10 Issue: 3 Year: 2010 Page: 236-249
Author(s): Mangeng Cheng, Gregory R. Ott
Anaplastic Lymphoma Kinase Inhibitors in Non-Small Cell Lung Cancer
Journal: Current Drug Targets
Volume: 17 Issue: 6 Year: 2016 Page: 739-745
Author(s): David M. Straughan, Sa d C. Azoury, Vivek Shukla
Identification of Novel Structurally Diverse Anaplastic Lymphoma Kinase Inhibitors Based on Pharmacophore Modeling, Virtual Screening and Molecular Docking
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 19 Issue: 9 Year: 2016 Page: 691-704
Author(s): Rong You,Lu Zhou,Liangliang Zhong,Xiaoli Li,Suwen Zhou,Yahui Tian
Treatment of Anaplastic Thyroid Cancer: Is there a Role for PPARγ Agonists?
Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 2 Issue: 3 Year: 2008 Page: 194-199
Author(s): Alessandro Antonelli, Silvia M. Ferrari, Poupak Fallahi, Piero Berti, Gabriele Materazzi, Emiliano Ghiri, Angelo Carpi, Andrea Nicolini, Paolo Miccoli
Prospecting for New Inhibitors of Anaplastic Lymphoma Kinase, A Clinically Relevant Oncogenic Drug Target
Journal: Current Bioactive Compounds
Volume: 13 Issue: 3 Year: 2017 Page: 236-243
Author(s): Daniel F. Kawano,Carlton A. Taft,Carlos H.T.P. da Silva
Crizotinib Versus Chemotherapy on ALK-positive NSCLC: A Systematic Review of Efficacy and Safety
Journal: Current Cancer Drug Targets
Volume: 19 Issue: 1 Year: 2019 Page: 41-49
Author(s): Mingxia Wang,Guanqi Wang,Haiyan Ma,Baoen Shan
Recent Development in the Discovery of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Non-small Cell Lung Cancer
Journal: Current Medicinal Chemistry
Volume: 24 Issue: 6 Year: 2017 Page: 590-613
Author(s): Jingru Liu,Shutao Ma
Lipoamino Acid Prodrugs of Paclitaxel: Synthesis and Cytotoxicity Evaluation on Human Anaplastic Thyroid Carcinoma Cells
Journal: Current Cancer Drug Targets
Volume: 9 Issue: 2 Year: 2009 Page: 202-213
Author(s): R. Pignatello, D. Paolino, V. Panto, V. Pistara, M. G. Calvagno, D. Russo, G. Puglisi, M. Fresta
Current Strategies to Overcome Resistance to ALK-Inhibitor Agents
Journal: Current Drug Metabolism
Volume: 16 Issue: 7 Year: 2015 Page: 585-596
Author(s): Francesca Simionato,Melissa Frizziero,Carmine Carbone,Giampaolo Tortora,Davide Melisi
A Review on Anaplastic Lymphoma Kinase (ALK) Rearrangements andMutations: Implications for Gastric Carcinogenesis and Target Therapy
Journal: Current Protein & Peptide Science
Volume: 25 Issue: 7 Year: 2024 Page: 539-552
Author(s): Felipe Pantoja Mesquita,Luina Benevides Lima,Emerson Lucena da Silva,Pedro Filho Noronha Souza,Maria Elisabete Amaral de Moraes,Rommel Mario Rodrigues Burbano,Raquel Carvalho Montenegro